Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susumu Takeuchi

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Molecular Pharmaceutics|June 3, 2011
A perspective for biowaivers of human bioequivalence studies on the basis of the combination of the ratio of AUC to the dose and the biopharmaceutics classification systemShinji Sakuma, Hidehisa Tachiki, Hitoshi Uchiyama, et al.
Cancer Medicine|June 26, 2024
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathwayYasuhiro Kato, Masaru Matsumoto, Natsuki Takano, et al.
Translational Lung Cancer Research|February 9, 2026
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysisYuto Terashima, Susumu Takeuchi, Yusuke Ishibashi, et al.
Respiratory Investigation|May 15, 2026
Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalitiesShun Idei, Yosuke Tanaka, Fushi Dong, et al.
Journal for Immunotherapy of Cancer|March 1, 2019
Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case reportTeppei Sugano, Masahiro Seike, Yoko Funasaka, et al.
Translational Lung Cancer Research|April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumoniasYuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.
Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.
Thoracic Cancer|February 26, 2020
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancerTeppei Sugano, Masahiro Seike, Yoshinobu Saito, et al.
International Journal of Clinical Oncology|July 29, 2019
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II studyAya Fukuizumi, Yuji Minegishi, Miwako Omori, et al.
Oxford Medical Case Reports|October 27, 2018
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravisTakehiro Tozuka, Teppei Sugano, Rintaro Noro, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Molecular Pharmaceutics|June 3, 2011
A perspective for biowaivers of human bioequivalence studies on the basis of the combination of the ratio of AUC to the dose and the biopharmaceutics classification systemShinji Sakuma, Hidehisa Tachiki, Hitoshi Uchiyama, et al.
Cancer Medicine|June 26, 2024
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathwayYasuhiro Kato, Masaru Matsumoto, Natsuki Takano, et al.
Translational Lung Cancer Research|February 9, 2026
Retrospective study on the tolerability using a four-cycle completion in elderly patients with extensive-stage small-cell lung cancer: a body mass index-based analysisYuto Terashima, Susumu Takeuchi, Yusuke Ishibashi, et al.
Respiratory Investigation|May 15, 2026
Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalitiesShun Idei, Yosuke Tanaka, Fushi Dong, et al.
Journal for Immunotherapy of Cancer|March 1, 2019
Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case reportTeppei Sugano, Masahiro Seike, Yoko Funasaka, et al.
Translational Lung Cancer Research|April 15, 2026
Prognostic impact of thyroid transcription factor-1 expression and the efficacy of carboplatin plus (nab-) paclitaxel in non-squamous non-small cell lung cancer complicated with idiopathic interstitial pneumoniasYuto Terashima, Aya Fukuizumi, Koichiro Kamio, et al.
Japanese Journal of Clinical Oncology|September 19, 2024
A single-institution retrospective study of comprehensive genomic profiling tests based on C-CAT findings for advanced solid cancersSusumu Takeuchi, Akinobu Yoshimura, Atsushi Sofuni, et al.
Thoracic Cancer|February 26, 2020
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancerTeppei Sugano, Masahiro Seike, Yoshinobu Saito, et al.
International Journal of Clinical Oncology|July 29, 2019
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II studyAya Fukuizumi, Yuji Minegishi, Miwako Omori, et al.
Oxford Medical Case Reports|October 27, 2018
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravisTakehiro Tozuka, Teppei Sugano, Rintaro Noro, et al.
Pageof 7